Adjuvant chemotherapy for patients with rectal cancer?

Lancet Oncol. 2014 Oct;15(11):1185-6. doi: 10.1016/S1470-2045(14)70411-5. Epub 2014 Sep 4.

Authors

Anne J Breugom¹, Cornelis J H van de Velde²

Affiliations

¹ Department of Surgery, Leiden University Medical Centre, 2300 RC Leiden, Netherlands.
² Department of Surgery, Leiden University Medical Centre, 2300 RC Leiden, Netherlands. Electronic address: C.J.H.van_de_Velde@lumc.nl.

PMID: 25201359
DOI: 10.1016/S1470-2045(14)70411-5

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Chemoradiotherapy / methods*
Female
Fluorouracil / therapeutic use
Humans
Leucovorin / therapeutic use
Male
Neoadjuvant Therapy / methods*
Organoplatinum Compounds / therapeutic use
Rectal Neoplasms / drug therapy*
Rectal Neoplasms / pathology*

Substances

Organoplatinum Compounds
Leucovorin
Fluorouracil

Supplementary concepts

Folfox protocol